Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis

MLA

Mannion, Melissa L., et al. “Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis.” Arthritis Care and Research, vol. 76, no. 8, Aug. 2024, pp. 1090–98. EBSCOhost, https://doi.org/10.1002/acr.25339.

APA

Mannion, M. L., Amin, S., Balevic, S., Chang, M., Correll, C. K., Kearsley, F. L., Hyrich, K. L., Beukelman, T., Aamir, R., Abulaban, K., Adams, A., Aguiar Lapsia, C., Akinsete, A., Akoghlanian, S., Al Manaa, M., AlBijadi, A., Allenspach, E., Almutairi, A., Alperin, R., … Zhu, A. (2024). Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis. Arthritis Care and Research, 76(8), 1090–1098. https://doi.org/10.1002/acr.25339

Chicago

Mannion, Melissa L., Shahla Amin, Stephen Balevic, Min‐Lee Chang, Colleen K. Correll, Fleet, Lianne Kearsley, Kimme L. Hyrich, et al. 2024. “Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis.” Arthritis Care and Research 76 (8): 1090–98. doi:10.1002/acr.25339.